Immunoassays and Clinical Chemistry Made Easy With DRG:HYBRID-XL
The DRG:HYBRID-XL fully automated random access analyzer is the perfect fit for medium or small laboratories. Its compact size can deliver to large demand and can be your primary machine to provide diagnostics to clients.
DRG:HYBRID-XL: Specs At A Glance
DRG:HYBRID-XL can handle up to 40 tests, including 40x of the same test or 40 separate tests, and 20-patient samples can be ordered in a wide range of pre-packaged tests to serve different specialties. Handling the DRG:HYBRID-XL is convenient to use with its included 8.5 inch color touchscreen monitor. The user is guided through easy-to-follow prompted menus to begin running diagnostics on the desired assay(s). During the “prepare run” step in setting up the DRG:HYBRID-XL, a scan option allows for easy organization of the assay(s) to be tested.
DRG:HYBRID-XL: Features That Matter
DRG:HYBRID-XL has a barcode/QR scanner and all codes for samples and reagents in user database can instantly be recognized and labeled within the system. The scan feature allows the user to maintain organization and also saves time labeling each sample/reagent individually. In addition, there is a manual input option to label the sample IDs.
The controls used in testing are also scanned into the system and loaded into a sample tray that can simultaneously hold up to 20 controls or samples. The user is easily guided through each step with the DRG:HYBRID-XL monitor (ASTM bi-directional interface) to ensure all precautions and necessary materials have been checked.
DRG:HYBRID-XL Feature Highlight: Usability
The DRG:HYBRID-XL rotor opens once prompted by the next menu in the procedure. This allows the user to load enough ready-to-use cartridges to meet the requirements of the tests being run. After the user has completed all of the pre-testing steps in the procedure, the DRG:HYBRID-XL will do the rest!
DRG:HYBRID-XL Feature Highlight: High Quality and Fast
First results are ready in as little as 10 minutes*. The DRG:HYBRID-XL can run up to 120 tests/day (or 3 complete runs). Normal run time can take from 90-120 minutes. It has clot detection, liquid level detection, and with a comfortable size (60,8 x 63,5 x 58,6 cm high) DRG:HYBRID-XL is the perfect Benchtop Analyzer.
*Clin. Chem. Results can be ready in as little as 10 minutes.
Latest posts by Gregory C. Guest (see all)
- DRG TM-CA 72-4 ELISA Kit used in NYU Winthrop Hospital Cancer Study! - July 26, 2017
- DRG Attends ASM 2017 in New Orleans! - June 13, 2017
- 1930 – 2017: Dr. Cyril E. Geacintov – Founder, President & CEO of DRG - May 31, 2017
News and Updates
DRG is proud to announce that our TM-CA 72-4 ELISA Kit (EIA-5071) has been used in a recent cancer study done by NYU Winthrop Hospital. The DRG TM-CA 72-4 ELISA Kit is for sale in the United States as an RUO product and is CE marked for global sales. Please see...read more
DRG International, Inc., the authorized distributor for CHROMagar, recently attended the 2017 ASM Microbe General Meeting of the American Society for Microbiology in New Orleans, LA from June 1, 2017 – June 4, 2017. Attendees (pictured above, l to r) were Mr. Alberto...read more
Dear Customers, Suppliers, and Friends, We regret to inform you that Dr. Cyril E. Geacintov passed away on Tuesday, May 23. His death was sudden and unexpected. In his usual driven style he was working in the office until a few days ago and challenging his team on how...read more
DRG International, inc. recently launched our brand new Ecommerce site for USA customers! Click here to shop over 180 ELISA, Salivary ELISA, and CHROMagar products now: https://store.drg-international.com/ The Ecommerce store has over 180 products that are FDA...read more
DRG Booth with Visitors. From Left: Mr. Gideon Lim; Dr. Cyril E. Geacintov, CEO & Founder of DRG; Dr.Aw Tar Choon, MD at Changi General Hospital in Singapore; Mrs. Josephine Teo; Mrs. Elke Geacintov; Mr. Wilhelm Sanger. We are pleased to announce that the DRG...read more
DRG’s CA 72-4 ELISA Kit (EIA-5071), which uses antibodies licensed from the NIH, has been used in a recent study conducted by Winthrop University. The study used the DRG CA 72-4 ELISA Kit (EIA-5071) to explore the expression of CA72-4 compared to current FDA-approved...read more
DRG is pleased to officially announce that we are going to Medlab Dubai from February 6th-February 9th, 2017 at the Dubai International Convention & Exhibition Centre, attended by over 10,000 delegates. The conference features 11 CME-accredited conference...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them questions about what makes them the worldwide leader in diagnostics. These are the key takeaways the top executives at DRG want you to remember. Michael Martini (full...read more
DRG’s staff is diverse and the company maintains a global presence requiring its staff to speak multiple languages as well as travel the world visiting DRG’s many offices and events. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them each about what DRG’s strengths are and how they add value to customers and business partners. Wilhelm Saenger (full profile) Our flexibility, flexibility and...read more
As a worldwide leader in diagnostics with several locations spanning the globe, DRG is proud to have a diverse, multilingual staff. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked each of them about the languages they...read more
Maximilian Saenger, son of the General Manager of DRG Germany (Wilhelm Saenger), traveled to Bishkek, capital of Kyrgyz Republic, during his summer vacation in August 2016.read more